Proteomics is the large-scale study of the complete set of proteins, or proteome, found in an organism.
The human body expresses a wide variety of proteins, highlighting their diverse roles. Unlike DNA or RNA, proteins fold into diverse shapes and sizes, determined by their molecular composition and functional role. Additionally, proteins exhibit spatial and temporal variation in expression, depending on factors such as cell type, developmental stage and environmental conditions.
For this reason, quantifying absolute protein expression experimentally is complex and challenging.
In addition to their dynamic expression, proteins often undergo post-translational modifications (PTMs); crucial chemical alterations enabling their biological functionality. Monitoring these changes enables researchers to understand different cellular processes, which is important for understanding disease mechanisms.
Despite these analytical challenges, proteomics provides substantial advantages for biomarker discovery, significantly aiding disease monitoring and therapeutic purposes.
Therefore, with the rapid advancement of mass spectrometry techniques and bioinformatics, proteomics is becoming increasingly important in understanding cellular dynamics and disease mechanisms.
Significance of Proteomics Research in Biomarker Discovery
The majority of known drug targets are proteins. Proteomics can directly identify biomarkers, significantly accelerating drug discovery pipelines, both independently and through integration with other multi-omics approaches.
Proteomics research offers several advantages in biomarker discovery, some of which include:
- Targeted Drug Insights: Proteins are the workhorses of the cell. By directly studying proteins and their levels of activity within the cell, researchers can obtain a blueprint for targeted drug development.
- Understanding the Interactome: Proteins work in a concerted fashion to execute various cellular functions. Elucidating protein–protein interactions through targeted proteomics generates a comprehensive map for understanding cellular dynamics, providing a useful tool to identify therapeutic targets for multivariate diseases such as cancer.
- Direct Monitoring of Disease Progression and Treatment Response: Proteins are often secreted into the plasma, urine or cerebrospinal fluid, making them relatively simple to isolate and monitor in routine healthcare settings for diagnostic, predictive or prognostic purposes.
Proteomics-driven biomarker discovery has many direct clinical applications, such as early-stage diagnosis (diagnostic biomarker), monitoring disease progression and severity (prognostic biomarker), and predicting treatment response (predictive biomarker).
For example, in breast cancer research, the overexpression of Human Epidermal Growth Factor 2 (HER2) is a diagnostic and predictive biomarker.
Predictive biomarkers are used to predict a patient’s likelihood to respond to a specific treatment. An HER2-positive patient may be classified as likely responders to treatments such as trastuzumab, lapatinib, and as non-responders to hormonal therapy.
Many diseases are regulated at the protein level. Studying them directly is therefore crucial to mapping disease mechanisms and developing targeted therapeutics. This is done by integrating mass spectrometry with appropriate bioinformatics tools.
Addressing Proteomics Data Analysis Challenges
The majority of large-scale proteomics experiments are done with mass spectrometry (MS), which generates huge volumes of multi-dimensional data.
Converting MS-outputs into identified proteins is a monumental computational task that requires sophisticated compute resources and bioinformatics tools for data processing, analysis and visualization.
A single MS-experiment can identify thousands of proteins and tens of thousands of peptides (protein fragments). Each has associated intensity values, retention times, and spectral information, making it challenging to efficiently manage, store, and process.
Finally, proteomics datasets frequently contain missing values, necessitating sophisticated analytical methods to impute them.
Interpreting complex proteomics datasets thus presents a formidable challenge to most bench-scientists who may not have the relevant bioinformatics or IT expertise.
Quark simplifies proteomics research by streamlining data analysis through the proteomics pipeline available on our no-code platform. Bench-scientists and bioinformaticians can get early exploratory insights from their proteomics data, with:
- Consolidated Sample-level Data Visualization: Quark enables researchers to quickly scan sample-level spectral information relating to Total Ion Chromatogram (TIC), Base Peak Chromatogram, and Extracted Peak Intensities, to visually compare them, within a few minutes of completing the pipeline run.
Proteomics Data Visualization: Sample-level spectral information
- Single Dashboard Quality Control Reports: Researchers can directly assess pMulti QC reports right from the data visualization module, eliminating the need to download separate files.
Proteomics Data Visualization: Consolidated quality control reports
- Instantly Generated Tertiary Data Analysis Plots: Bench-scientists may instantly compare multiple cohorts and access differential protein expression data using volcano plots, heat maps and bar plots.
Proteomics Data Visualization: Early Exploratory Data Analysis
Conclusion
Proteomics experiments capture snapshots of thousands of proteins simultaneously, enabling researchers to directly probe disease mechanisms and understand cellular dynamics.
Despite challenges in validating protein expression and functionality, proteomics is rapidly becoming essential in clinical and healthcare applications, driving the demand for intuitive platforms capable of streamlined data analysis, visualization and interpretation.
Quark integrates proteomics data analysis with no-code, accelerated early exploratory insights, enabling bench-scientists to interpret complex, multi-dimensional data without needing bioinformatics or IT expertise.
By accelerating data analysis, visualization and interpretation, Quark provides researchers with an early head-start in identifying biomarkers of interest to their studies.
Request a demo to learn more about Quark.